Cubist Systematic Strategies’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,192	Closed	-$18K	–	3631
2023 Q4	$18K	Buy	+7,192	New	+$14.1K	﹤0.01%	3360
2023 Q2	–	Sell	-119,193	Closed	-$361K	–	3409
2023 Q1	$361K	Buy	+119,193	New	+$336K	﹤0.01%	2866
2022 Q4	–	Sell	-10,726	Closed	-$20K	–	4188
2022 Q3	$20K	Sell	10,726 -30,021	-74%	-$70.7K	﹤0.01%	4242
2022 Q2	$110K	Sell	40,747 -154,717	-79%	-$396K	﹤0.01%	3943
2022 Q1	$582K	Sell	195,464 -68,124	-26%	-$209K	﹤0.01%	2437
2021 Q4	$1.02M	Buy	263,588 +249,988	+1,838%	+$971K	0.01%	1895
2021 Q3	$58K	Sell	13,600 -50,100	-79%	-$167K	﹤0.01%	2821
2021 Q2	$193K	Sell	63,700 -121,815	-66%	-$377K	﹤0.01%	2577
2021 Q1	$618K	Buy	185,515 +134,616	+264%	+$519K	0.01%	1839
2020 Q4	$181K	Buy	+50,899	New	+$178K	﹤0.01%	2272
2020 Q3	–	Sell	-12,562	Closed	-$23K	–	2464
2020 Q2	$23K	Buy	+12,562	New	+$20.6K	﹤0.01%	2310
2020 Q1	–	Sell	-895	Closed	-$2K	–	2128
2019 Q4	$2K	Buy	+895	New	+$1.45K	﹤0.01%	2385
2017 Q4	–	Sell	-300	Closed	-$2K	–	1877
2017 Q3	$2K	Buy	+300	New	+$1.28K	﹤0.01%	1810
2015 Q3	–	Sell	-1,634	Closed	-$19K	–	1838
2015 Q2	$19K	Buy	1,634 +1,534	+1,534%	+$23.3K	﹤0.01%	1756
2015 Q1	$2K	Buy	+100	New	+$2.05K	﹤0.01%	1859